It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PAX’s FA Score shows that 1 FA rating(s) are green whileTMDX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PAX’s TA Score shows that 5 TA indicator(s) are bullish while TMDX’s TA Score has 5 bullish TA indicator(s).
PAX (@Investment Managers) experienced а +5.01% price change this week, while TMDX (@Medical Specialties) price change was +5.96% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +2.64%. For the same industry, the average monthly price growth was -3.11%, and the average quarterly price growth was -3.13%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.
PAX is expected to report earnings on Jul 31, 2025.
TMDX is expected to report earnings on Jul 31, 2025.
Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Medical Specialties (+5.62% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
PAX | TMDX | PAX / TMDX | |
Capitalization | 2.2B | 2.4B | 92% |
EBITDA | 143M | -7.7M | -1,856% |
Gain YTD | -8.724 | 49.960 | -17% |
P/E Ratio | 18.37 | N/A | - |
Revenue | 307M | 242M | 127% |
Total Cash | 12.8M | 395M | 3% |
Total Debt | 15.6M | 516M | 3% |
TMDX | ||
---|---|---|
OUTLOOK RATING 1..100 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 50 | |
SMR RATING 1..100 | 46 | |
PRICE GROWTH RATING 1..100 | 38 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PAX | TMDX | |
---|---|---|
RSI ODDS (%) | 4 days ago73% | 4 days ago79% |
Stochastic ODDS (%) | 4 days ago67% | 4 days ago73% |
Momentum ODDS (%) | 4 days ago67% | 4 days ago84% |
MACD ODDS (%) | 4 days ago65% | 4 days ago76% |
TrendWeek ODDS (%) | 4 days ago64% | 4 days ago87% |
TrendMonth ODDS (%) | 4 days ago60% | 4 days ago89% |
Advances ODDS (%) | 4 days ago65% | 5 days ago85% |
Declines ODDS (%) | 21 days ago69% | 25 days ago81% |
BollingerBands ODDS (%) | 4 days ago70% | 4 days ago75% |
Aroon ODDS (%) | 4 days ago56% | N/A |
A.I.dvisor indicates that over the last year, PAX has been closely correlated with BN. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PAX jumps, then BN could also see price increases.
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RDNT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RDNT could also see price increases.
Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
---|---|---|---|---|
TMDX | 100% | -0.72% | ||
RDNT - TMDX | 40% Loosely correlated | -0.38% | ||
CDNA - TMDX | 34% Loosely correlated | -0.05% | ||
GKOS - TMDX | 34% Loosely correlated | +1.31% | ||
ALGN - TMDX | 33% Poorly correlated | -0.50% | ||
LIVN - TMDX | 32% Poorly correlated | N/A | ||
More |